Anti-C1q antibodies are associated with systemic lupus erythematosus global activity but not specifically with nephritis: A controlled study of 126 consecutive patients

Arthritis and Rheumatism

Volumn 63, Issue 8, 2011, Pages 2436-2444

  Katsumata, Yasuhiro ^a   Miyake, Kohei ^a   Kawaguchi, Yasushi ^a   Okamoto, Yuko ^a   Kawamoto, Manabu ^a   Gono, Takahisa ^a   Baba, Sayumi ^a   Hara, Masako ^a   Yamanaka, Hisashi ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C1Q ANTIBODY; COMPLEMENT COMPONENT C3 RECEPTOR; COMPLEMENT COMPONENT C4; DOUBLE STRANDED DNA ANTIBODY;

ALOPECIA; ANEMIA; ANTIBODY TITER; ARTICLE; COMPARATIVE STUDY; COMPLEMENT ACTIVATION; CONTROLLED STUDY; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEVER; HOSPITAL ADMISSION; HUMAN; HYPOCOMPLEMENTEMIA; INFLAMMATION; LEUKOPENIA; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MYOSITIS; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY; SEROLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; THROMBOCYTOPENIA; UNIVERSITY HOSPITAL; VASCULITIS;

ADOLESCENT; ADULT; AUTOANTIBODIES; CASE-CONTROL STUDIES; COMPLEMENT C1Q; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MALE; MIDDLE AGED;

EID: 79961100600     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.30401     Document Type: Article

References (36)

1. Kurien BT, Scofield RH,. Autoantibody determination in the diagnosis of systemic lupus erythematosus. Scand J Immunol 2006; 64: 227-35. (Pubitemid 44215112)
2. Giles I, Putterman C,. Autoantibodies and other biomarkers: pathological consequences (1). Lupus 2008; 17: 241-6. (Pubitemid 351588951)
3. Rahman A, Isenberg DA,. Systemic lupus erythematosus. N Engl J Med 2008; 358: 929-39. (Pubitemid 351397092)
4. Marto N, Bertolaccini ML, Calabuig E, Hughes GR, Khamashta MA,. Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus. Ann Rheum Dis 2005; 64: 444-8. (Pubitemid 40283057)
5. Uwatoko S, Aotsuka S, Okawa M, Egusa Y, Yokohari R, Aizawa C, et al. Characterization of C1q-binding IgG complexes in systemic lupus erythematosus. Clin Immunol Immunopathol 1984; 30: 104-16. (Pubitemid 14219649)
6. Kallenberg CG,. Anti-C1q autoantibodies. Autoimmun Rev 2008; 7: 612-5.
7. Trendelenburg M, Courvoisier S, Spath PJ, Moll S, Mihatsch M, Itin P, et al. Hypocomplementemic urticarial vasculitis or systemic lupus erythematosus? Am J Kidney Dis 1999; 34: 745-51. (Pubitemid 29473064)
8. Seelen MA, Trouw LA, Daha MR,. Diagnostic and prognostic significance of anti-C1q antibodies in systemic lupus erythematosus. Curr Opin Nephrol Hypertens 2003; 12: 619-24. (Pubitemid 38186753)
9. Trendelenburg M, Lopez-Trascasa M, Potlukova E, Moll S, Regenass S, Fremeaux-Bacchi V, et al. High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis. Nephrol Dial Transplant 2006; 21: 3115-21. (Pubitemid 44567082)
10. Moroni G, Radice A, Giammarresi G, Quaglini S, Gallelli B, Leoni A, et al. Are laboratory tests useful for monitoring the activity of lupus nephritis? A 6-year prospective study in a cohort of 228 patients with lupus nephritis. Ann Rheum Dis 2009; 68: 234-7.
11. Flierman R, Daha MR,. Pathogenic role of anti-C1q autoantibodies in the development of lupus nephritis: a hypothesis. Mol Immunol 2007; 44: 133-8. (Pubitemid 44754840)
12. Horvath L, Czirjak L, Fekete B, Jakab L, Pozsonyi T, Kalabay L, et al. High levels of antibodies against Clq are associated with disease activity and nephritis but not with other organ manifestations in SLE patients. Clin Exp Rheumatol 2001; 19: 667-72. (Pubitemid 34026830)
13. Gunnarsson I, Sundelin B, Heimburger M, Forslid J, van Vollenhoven R, Lundberg I, et al. Repeated renal biopsy in proliferative lupus nephritis: predictive role of serum C1q and albuminuria. J Rheumatol 2002; 29: 693-9. (Pubitemid 34303862)
14. Heidenreich U, Mayer G, Herold M, Klotz W, Stempfl Al-Jazrawi K, Lhotta K,. Sensitivity and specificity of autoantibody tests in the differential diagnosis of lupus nephritis. Lupus 2009; 18: 1276-80.
15. Grootscholten C, Dieker JW, McGrath FD, Roos A, Derksen RH, van der Vlag J, et al. A prospective study of anti-chromatin and anti-C1q autoantibodies in patients with proliferative lupus nephritis treated with cyclophosphamide pulses or azathioprine/methylprednisolone. Ann Rheum Dis 2007; 66: 693-6. (Pubitemid 46707143)
16. Fang QY, Yu F, Tan Y, Xu LX, Wu LH, Liu G, et al. Anti-C1q antibodies and IgG subclass distribution in sera from Chinese patients with lupus nephritis. Nephrol Dial Transplant 2009; 24: 172-8.
17. Horak P, Hermanova Z, Zadrazil J, Ciferska H, Ordeltova M, Kusa L, et al. C1q complement component and -antibodies reflect SLE activity and kidney involvement. Clin Rheumatol 2006; 25: 532-6. (Pubitemid 44143752)
18. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7. (Pubitemid 13221242)
19. Hochberg MC, for the Diagnostic and Therapeutic Criteria Committee of the American College of Rheumatology. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997; 40: 1725.
20. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24. (Pubitemid 18091653)
21. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581-90.
22. Gladman DD, Ibanez D, Urowitz MB,. Systemic Lupus Erythematosus Disease Activity Index 2000. J Rheumatol 2002; 29: 288-91. (Pubitemid 34118775)
23. ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999; 42: 599-608.
24. Katsumata Y, Harigai M, Kawaguchi Y, Fukasawa C, Soejima M, Takagi K, et al. Diagnostic reliability of cerebral spinal fluid tests for acute confusional state (delirium) in patients with systemic lupus erythematosus: interleukin 6 (IL-6), IL-8, interferon-α, IgG index, and Q-albumin. J Rheumatol 2007; 34: 2010-7. (Pubitemid 47548203)
25. Katsumata Y, Harigai M, Kawaguchi Y, Fukasawa C, Soejima M, Kanno T, et al. Diagnostic reliability of magnetic resonance imaging for central nervous system syndromes in systemic lupus erythematosus: a prospective cohort study. BMC Musculoskelet Disord 2010; 11: 13.
26. Aydogan K, Karadogan SK, Adim SB, Tunali S,. Hypocomplementemic urticarial vasculitis: a rare presentation of systemic lupus erythematosus. Int J Dermatol 2006; 45: 1057-61. (Pubitemid 44317119)
27. Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 2004; 65: 521-30. (Pubitemid 38130646)
28. Uwatoko S, Aotsuka S, Okawa M, Egusa Y, Yokohari R, Aizawa C, et al. C1q solid-phase radioimmunoassay: evidence for detection of antibody directed against the collagen-like region of C1q in sera from patients with systemic lupus erythematosus. Clin Exp Immunol 1987; 69: 98-106. (Pubitemid 17089323)
29. Armstrong DJ, Crockard AD, Whitehead EM, Bell AL,. Anti-C1q antibodies in renal and non-renal SLE. Ann Rheum Dis 2005; 64: 1108. (Pubitemid 40909541)
30. Sontheimer RD, Racila E, Racila DM,. C1q: its functions within the innate and adaptive immune responses and its role in lupus autoimmunity. J Invest Dermatol 2005; 125: 14-23. (Pubitemid 40981419)
31. Lood C, Gullstrand B, Truedsson L, Olin AI, Alm GV, Ronnblom L, et al. C1q inhibits immune complex-induced interferon-α production in plasmacytoid dendritic cells: a novel link between C1q deficiency and systemic lupus erythematosus pathogenesis. Arthritis Rheum 2009; 60: 3081-90.
32. Sinico RA, Rimoldi L, Radice A, Bianchi L, Gallelli B, Moroni G,. Anti-C1q autoantibodies in lupus nephritis. Ann N Y Acad Sci 2009; 1173: 47-51.
33. Wu FQ, Zhao Q, Cui XD, Zhang W,. C1q and anti-C1q antibody levels are correlated with disease severity in Chinese pediatric systemic lupus erythematosus. Rheumatol Int 2011; 31: 501-5.
34. Uwatoko S, Gauthier VJ, Mannik M,. Autoantibodies to the collagen-like region of C1Q deposit in glomeruli via C1Q in immune deposits. Clin Immunol Immunopathol 1991; 61: 268-73.
35. Trendelenburg M,. Antibodies against C1q in patients with systemic lupus erythematosus. Springer Semin Immunopathol 2005; 27: 276-85. (Pubitemid 41639881)
36. Walport MJ, Davies KA, Botto M,. C1q and systemic lupus erythematosus. Immunobiology 1998; 199: 265-85. (Pubitemid 28404347)